Naftidrofuryl
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.045.960 |
| Chemical and physical data | |
| Formula | C24H33NO3 |
| Molar mass | 383.524 g/mol g·mol−1 |
Naftidrofuryl (INN, also known as nafronyl or as the oxalate salt nafronyl oxalate) is a drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.[1] It may also be a 5-HT2 receptor antagonist.
It is sold under the brand name Dusodril (Merck).
Historically, it has been used to treat sudden idiopathic hearing loss and acute tinnitus.[2]
References
- ^ Reynolds, J.E.F. (ed.) (1993). Martindale: The extra pharmacopoeia (30th edition ed.). London: Pharmaceutical Press. p. 1310. ISBN 0853693005.
{{cite book}}:|author=has generic name (help);|edition=has extra text (help) - ^ http://www.der-arzneimittelbrief.de/Jahrgang2004/Ausgabe12Seite89.htm
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |